Silexion Therapeutics (SLXN) Income Statement (2020 - 2026)
Income Statement report data from Dec 31, 2020 to Mar 31, 2026 for Silexion Therapeutics (SLXN).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||
Cost Of Revenue | - | - | - | - | - | - | 20K (+100.00%) | 10K | - | - | - | - | - | - | - | - | - | - | - | - |
Costof Goods And Services Sold | - | - | - | - | - | - | 20K (+100.00%) | 10K | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit | - | - | - | - | - | - | -20.00K (+100.00%) | -10.00K | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | ||||||||||||||||||||
Research And Development | 1.37M (-59.47%) | 3.38M (+56.48%) | 2.16M (+111.76%) | 1.02M (+72.88%) | 590K (-32.18%) | 870K (-72.98%) | 3.22M (+318.18%) | 770K (-19.79%) | 960K (-23.81%) | 1.26M (+133.33%) | 540K | - | - | - | - | - | - | - | - | - |
Selling General And Administrative | 1.38M (+33.98%) | 1.03M (-8.85%) | 1.13M (-10.32%) | 1.26M (+18.87%) | 1.06M (+2.91%) | 1.03M (-78.54%) | 4.80M (+686.89%) | 610K (+117.86%) | 280K (-40.43%) | 470K (+147.37%) | 190K | - | - | - | - | - | - | - | - | - |
Operating Expenses | 2.75M | -18.86M | 3.29M (+44.30%) | 2.28M (+38.18%) | 1.65M (-13.16%) | 1.90M (-76.28%) | 8.01M (+480.43%) | 1.38M (+10.40%) | 1.25M (-27.75%) | 1.73M (+136.99%) | 730K (+48.98%) | 490K (+104.17%) | 240K (+50.00%) | 160K (-54.29%) | 350K (-18.60%) | 430K | - | 200K (+122.22%) | 90K (-55.00%) | 200K |
Depreciation And Amortization | - | - | - | - | - | - | 20K (+100.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K | - | - | - | - | - | - | - | - | - |
Operating Income | ||||||||||||||||||||
Operating Income | -2.75M | 19M | -3.29M (+44.30%) | -2.28M (+38.18%) | -1.65M (-13.16%) | -1.90M (-76.37%) | -8.04M (+482.61%) | -1.38M (+10.40%) | -1.25M (-27.75%) | -1.73M (+136.99%) | -730.00K (+48.98%) | -490.00K (+104.17%) | -240.00K (+50.00%) | -160.00K (-54.29%) | -350.00K (-18.60%) | -430.00K | - | -200.00K (+122.22%) | -90.00K (-55.00%) | -200.00K |
Ebit | -2.73M (-38.10%) | -4.41M (+35.28%) | -3.26M (+30.40%) | -2.50M (+44.51%) | -1.73M (+8550.00%) | -20.00K (-99.83%) | -11.81M (+697.97%) | -1.48M (+4.23%) | -1.42M (-14.97%) | -1.67M (+108.75%) | -800.00K (+63.27%) | -490.00K (+104.17%) | -240.00K (+50.00%) | -160.00K (-54.29%) | -350.00K (-18.60%) | -430.00K | - | -200.00K (+122.22%) | -90.00K (-55.00%) | -200.00K |
EBITDA | -2.73M (-37.95%) | -4.40M (+34.97%) | -3.26M (+30.40%) | -2.50M (+45.35%) | -1.72M (-1.71%) | -1.75M (-85.14%) | -11.78M (+695.95%) | -1.48M (+4.96%) | -1.41M (-15.57%) | -1.67M (+111.39%) | -790.00K | 490K (+68.97%) | 290K (+625.00%) | 40K | -250.00K (+4.17%) | -240.00K (+9.09%) | -220.00K (+15.79%) | -190.00K (+90.00%) | -100.00K (-50.00%) | -200.00K |
Other Income / Expenses | ||||||||||||||||||||
Interest Income | 30K (-57.14%) | 70K (+75.00%) | 40K (0.00%) | 40K | - | 20K | - | 10K (-50.00%) | 20K (-33.33%) | 30K (-25.00%) | 40K | - | - | - | - | - | - | - | - | - |
Interest Expense | - | 10K | - | - | 10K | - | 50K | - | - | 40K | - | - | - | - | - | - | - | - | - | - |
Net Interest Income | 40K (-87.10%) | 310K (+416.67%) | 60K (+50.00%) | 40K | -90.00K (+200.00%) | -30.00K (-99.38%) | -4.84M | - | 20K (-75.00%) | 80K | - | - | - | - | - | - | - | - | - | - |
Net Income | ||||||||||||||||||||
Income Before Tax | -2.73M (-38.10%) | -4.41M (+35.28%) | -3.26M (+30.40%) | -2.50M (+44.51%) | -1.73M (-1.14%) | -1.75M (-85.24%) | -11.86M (+695.97%) | -1.49M (+4.93%) | -1.42M (-14.97%) | -1.67M (+108.75%) | -800.00K | 490K (+68.97%) | 290K (+625.00%) | 40K | -250.00K (+4.17%) | -240.00K (+9.09%) | -220.00K (+15.79%) | -190.00K (+90.00%) | -100.00K (-50.00%) | -200.00K |
Income Tax Expense | - | - | - | - | - | - | - | - | 10K (0.00%) | 10K (0.00%) | 10K | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -2.73M (-38.10%) | -4.41M (+35.28%) | -3.26M (+30.40%) | -2.50M (+44.51%) | -1.73M (-1.14%) | -1.75M (-85.24%) | -11.86M (+695.97%) | -1.49M (+4.93%) | -1.42M (-15.48%) | -1.68M (+107.41%) | -810.00K | - | - | - | - | - | - | - | - | - |
Net Income | -2.73M (-38.10%) | -4.41M (+35.28%) | -3.26M (+30.40%) | -2.50M (+44.51%) | -1.73M (-1.14%) | -1.75M (-85.23%) | -11.85M (+706.12%) | -1.47M (+7.30%) | -1.37M (-20.81%) | -1.73M (+118.99%) | -790.00K | 490K (+68.97%) | 290K (+625.00%) | 40K | -250.00K (+4.17%) | -240.00K (+9.09%) | -220.00K (+15.79%) | -190.00K (+90.00%) | -100.00K (-50.00%) | -200.00K |